跳至主要内容
临床试验/NCT01154972
NCT01154972已完成不适用

Preoperative Identification of the Sentinel Lymph Node in Breast Cancer, Using Ultrasound and Radio-isotope/Percutaneous Gamma Probe

NHS Tayside2 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2010年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
NHS Tayside
入组人数
59
试验地点
2
主要终点
Is the sentinel lymph node marked preoperatively confirmed as the SLN at surgery?

研究概览

简要总结

When a person has breast cancer it is necessary to find out whether the cancer has spread to the lymph nodes in the armpit because if it has, further treatment is likely to be needed. There are many of these nodes but when the breast cancer spreads, it does so in a step-by-step fashion, starting with the so-called Sentinel Lymph Node (SLN). At present, the only way to be sure whether there is cancer in the lymph nodes or not is to perform an operation to remove at least the SLN. If the pathologist finds cancer in the SLN, a second operation is usually required to remove further nodes in case they contain cancer too. Surgical removal of the lymph nodes in the armpit can cause difficulties for the patient afterwards, such as pain and swelling in the arm. If there is no cancer in the SLN, no further operations on the armpit are needed. The investigators wish to find out whether in some patients, operations on the armpit can be avoided completely. The first step in doing this is to test whether the investigators can find out which is the SLN before the operation, using a combination of an injection and ultrasound scanning. The injection - into the skin of the breast - would be a radioactive substance, which is the usual way the surgeon finds the SLN. The radioactive substance collects in the SLN and the investigators would use a "gamma probe" over the surface of the armpit to detect the radiation. In this initial study, the investigators would aim to find the SLN before the operation and place a marker wire in it so that the surgeon could check whether the investigators had found the correct node.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Diagnosed with invasive breast cancer suitable for primary surgical treatment
  • Booked for surgical Sentinel Lymph Node Biopsy

排除标准

  • Unable to give informed consent
  • Known bleeding disorder
  • Previous axillary surgery
  • Previously treated for the current tumour with chemotherapy or hormone therapy

研究组 & 干预措施

Single arm study - Sentinel Node Localisation

Experimental

干预措施: Preoperative sentinel lymph node identification and marking (Procedure)

结局指标

主要结局

Is the sentinel lymph node marked preoperatively confirmed as the SLN at surgery?

时间窗: 8 Months from start of trial.

次要结局

未报告次要终点

研究者

发起方
NHS Tayside
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Andy Evans

Professor of Breast Imaging

NHS Tayside

研究点 (2)

Loading locations...

相似试验

Preoperative Localisation of the Sentinel Lymph Node... | 临床试验